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BDE-99 impairs differentiation of 
human and mouse NPCs into the 
oligodendroglial lineage by species-
specific modes of action
Katharina Dach1, Farina Bendt1, Ulrike Huebenthal1, Susanne Giersiefer1, Pamela J. Lein2, 
Heike Heuer1 & Ellen Fritsche1
Polybrominated diphenyl ethers (PBDEs) are bioaccumulating flame retardants causing developmental 
neurotoxicity (DNT) in humans and rodents. Their DNT effects are suspected to involve thyroid 
hormone (TH) signaling disruption. Here, we tested the hypothesis whether disturbance of neural 
progenitor cell (NPC) differentiation into the oligodendrocyte lineage (O4+ cells) by BDE-99 involves 
disruption of TH action in human and mouse (h,m)NPCs. Therefore, we quantified differentiation 
of NPCs into O4+ cells and measured their maturation via expression of myelin-associated genes 
(hMBP, mMog) in presence and absence of TH and/or BDE-99. T3 promoted O4+ cell differentiation in 
mouse, but not hNPCs, and induced hMBP/mMog gene expression in both species. BDE-99 reduced 
generation of human and mouse O4+ cells, but there is no indication for BDE-99 interfering with cellular 
TH signaling during O4+ cell formation. BDE-99 reduced hMBP expression due to oligodendrocyte 
reduction, but concentrations that did not affect the number of mouse O4+ cells inhibited TH-induced 
mMog transcription by a yet unknown mechanism. In addition, ascorbic acid antagonized only the 
BDE-99-dependent loss of human, not mouse, O4+ cells by a mechanism probably independent of 
reactive oxygen species. These data point to species-specific modes of action of BDE-99 on h/mNPC 
development into the oligodendrocyte lineage.
Polybrominated diphenylethers (PBDEs) were widely used as flame retardants in consumer products and 
although mostly banned from the markets, they remain present in the environment1–4. Main PBDE exposure 
sources for adults, young children, babies and fetuses comprise food, house dust, breast milk and cord blood5,6. 
Due to combined exposure via house dust and breast milk, toddlers present the highest PBDE body burdens of 
all age groups7–9. Exposure during development is of high concern as PBDEs are developmentally neurotoxic for 
humans10: high prenatal PBDE exposure correlated with lower IQs, attention deficits and hyperactivity11–13.
Thyroid hormones (THs) play a fundamental role in brain development as they guide multiple neurodevelop-
mental processes in rodents14. Specifically, TH is essential for human and rodent myelin formation15–18, which is 
indispensable for proper functions of neurons19,20 and the entire brain21.
There is increasing evidence that PBDEs might act as TH disruptors on brain development. First, PBDEs 
decreased TH L-thyroxine (T4) and increased thyroid stimulating hormone (TSH) blood levels in rodents22,23. 
And second, in utero PBDE-exposed animals presented similar behavioral abnormalities (hyperactivity and habit-
uation decrease) and impaired learning24–26 as animals with propylthiouracil (PTU)-induced TH deficiency27. In 
humans, high PBDE measures were correlated with either decreased, increased or unchanged T4 and increased 
or decreased TSH blood levels28–31. In vitro, however, TH disruption of brominated diphenyl ether (BDE)− 99 was 
suspected as this compound reduced human O4+ cell formation from human neural progenitor cells (hNPCs)32. 
Whether TH disruption is indeed involved in PBDE-dependent disturbance of cellular TH actions on oligoden-
drogenesis remains elusive.
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To shed light on this question, this study aimed to elucidate if disturbance of TH signaling by BDE-99 inter-
feres with the neurodevelopmental process of oligodendrogenesis in vitro and thus might be a potential mode of 
action (MoA) of PBDE-induced DNT. First, we characterized the effects of BDE-99 on the formation of O4+ cells 
and their maturation in human and mouse NPCs (h,mNPCs). Second, we demonstrated the functionality of TH 
signaling in NPCs and assessed the species-specific contribution of TH to oligodendrocyte differentiation. Third, 
we elucidated the species-specific MoA of BDE-99 on the formation of O4+ cells and their maturation in hNPCs 
and mNPCs.
Results
BDE-99 reduces NPC differentiation to the oligodendrocyte lineage. Human and mouse NPCs 
grown as neurospheres migrate radially out of the sphere upon plating onto a poly-D-lysin/laminin matrix and 
form on average 6–8% O4+ cells/nuclei after 5 days of migration and simultaneous differentiation33,34. These 
percentages are similar to the oligodendrocyte fractions in human35,36 and mouse37,38 cortex in vivo supporting 
the physiological relevance of our findings. BDE-99 reduced differentiated O4+ cells/nuclei of both species con-
centration-dependently after 5 days without reducing viability (Fig. 1A,C). Human O4+ cell formation was found 
to be 7 times more sensitive towards the BDE-99 treatment than the murine process (IC50: 1.9 μ M and 13.6 μ M 
BDE-99 and IC20: 0.9 μ M and 6.9 μ M for hNPCs and mNPCs, respectively) showing significance in the nanomolar 
range (LOEAC 900 nM). Fluorescence microscope images illustrate the BDE-99-mediated reduction in O4+ cells 
after 5 days of differentiation (Fig. 1B,D) with the human IC50 concentration of 2 μ M not reducing number of 
mouse O4+ cells/nuclei (Supplementary Fig. S1).
TH signaling is functional in NPCs. Human and mouse NPCs, as also previously described by others39,40, 
express genes encoding for TH receptors (TRs) α and β (Supplementary Fig. S2A–D). Although the expression of 
the gene encoding for human TRβ 1 (THRB1) was significantly induced by the receptor active thyroid hormone 
L-triiodothyronine (T3), the low copy number change from 3 to 7 copies/10,000 β-actin makes a biological signif-
icance of this increase highly unlikely. Compared to the approximately 20-fold higher expression of TRα 1 in both 
species it is assumed that this receptor is more important at this stage of brain development. In vivo TRα 1 plays 
a role during early brain development and TRβ 1expression strongly increases postnatally in the rodent brain41. 
Functionality of TRs was demonstrated by T3-induced hairless mRNA expression (Supplementary Fig. S2E,F). 
Hairless is a TH-inducible gene in fetal brains in vivo42,43 that is TRα -dependent44. Furthermore, T3 induced its 
own metabolism by stimulating deiodinase 3 mRNA expression (Supplementary Fig. S2G,H).
TH effects on basal and BDE-99-reduced mouse and human O4+ cell formation. T3 and T4 only 
induced formation of O4+ cells/nuclei in mNPCs, but not in hNPCs after 5 days of differentiation (Fig. 2A,D). 
A T3 concentration of 3 nM was used for all further experiments because it is close to the total T3 concentration 
in human serum45–48 and produced the highest percentage of O4+ cells in mNPCs (Fig. 2D). After 5 days, 3 nM 
Figure 1. BDE-99 reduces NPC differentiation to the oligodendrocyte lineage. Human (A,B) and mouse 
(C,D) NPCs were differentiated with DMSO or increasing concentrations of BDE-99 (0.01–20 μ M) for 5 days. 
O4+ cells were immunocytochemically stained with an antibody against O4 and nuclei were counterstained 
with Hoechst 33258. Viability was measured with the Alamar-Blue assay two hours prior fixation. (A,C) Data 
for viability and the percentage of O4+ cells/nuclei in the migration area were normalized to the solvent control 
(mean ± SEM, n ≥ 3). A sigmoidal curve fit was applied and for oligodendrogenesis IC20 and IC50 values were 
calculated. The 95% confidence intervals are 0.7–1.0 μ M (human IC20); 1.6–2.2 μ M (human IC50); 5.7–8.3 μ M 
(mouse IC20) and 11.3–16.5 μ M (mouse IC50). Significant differences from the DMSO control are indicates as 
* (p < 0.05). (B,D) Illustration of human and mouse O4+ cells visualized by O4 immunofluorescence stainings 
after treatment with DMSO or the respective IC50 concentration of BDE-99 after five days of differentiation 
(scale bar: 50 μ m).
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T3 or T4 increased the percentage of O4+ cells/nuclei in control as well as in BDE-99 treated mNPCs, but not in 
hNPCs (Fig. 2B,E). Time-course experiments revealed that human O4+ cells form during the first 4 days of differ-
entiation. Treatment of the cells with T3 accelerated, but did not increase the percentage of human O4+ cells after 
5 days of differentiation. Moreover, T3 did not antagonize the inhibitory BDE-99 effect on human O4+ cell for-
mation at any time point (Fig. 2C). In mouse cultures, O4+ cells formed within the first 1–2 days and T3 induced 
their formation in control as well as in BDE-99-treated NPCs at all timepoints with a similar potency (Fig. 2F).
TH effects on basal and BDE-99-reduced mouse and human oligodendrocyte maturation. For 
investigating oligodendrocyte maturation, changes in expression of the oligodendrocyte-specific markers human 
myelin basic protein (hMBP) and murine myelin oligodendrocyte glycoprotein (mMog) were analyzed in the total 
neurosphere cell population over a time-course of 5 days (Fig. 3A,D). These different markers were used, because 
human oligodendrocytes do not express the late marker MOG after 5 days of differentiation due to their immatu-
rity, while for murine oligodendrocytes - due to their high maturation stage - Mbp was already highly expressed 
on day 1 of differentiation and did not increase over differentiation time (data not shown). We also confirmed 
this species-dependent difference in oligodendrocyte maturation stage by morphological analysis as branched, 
sheet-forming O4+ cells found in murine culture represent phenotypically a more mature state than the more 
linear O4+ cells observed in human cultures (Fig. 3C). Both, hMBP and mMog expression increased significantly 
during the 5 days of differentiation indicating oligodendrocyte maturation (Fig. 3A,D). During this time period, 
T3 significantly induced gene copy numbers of NPCs’ hMBP and mMog, while BDE-99 reduced T3-induced 
hMBP as well as mMog expression. To evaluate if this reduced hMBP and mMog expression is a consequence of 
reduced O4+ cell formation or rather a consequence of compromised oligodendrocyte maturation, hMBP and 
mMog expression after 5 days of differentiation were normalized to the percentage of O4+ cells in the respective 
cultures (6–8% O4+ cells; Fig. 3B,E) by calculation of the maturation quotient (QM):
= +Q MBP or Mog expression/% O4 cells (1)M
QM clearly revealed that 3 nM T3 significantly increased the maturation stage of oligodendrocytes in both 
species (human: 4.4-fold, mouse: 1.8-fold). Treatment of hNPCs with 2 μ M BDE-99 (IC50 concentration for inhi-
bition of human O4+ cell formation, Fig. 1) did not reduce human QM, neither alone nor in combination with T3 
Figure 2. TH effects on basal and BDE-99-reduced mouse and human O4+ cell formation. Human 
(A–C) and mouse (D–F) NPCs were differentiated for 5 days (A,B,D,E) or 1–5 days (C,F) under exposure to 
solvent(s), BDE-99 and/or TH (T3 or T4). Immunocytochemical stainings for O4+ cells and counterstainings 
with Hoechst 33258 for nuclei were performed. (A,D) Data on TH (0.003–30 nM) alone are shown as 
mean ± SEM (n = 3 (mouse), n = 4 (human)). (B,E) Results of the co-exposure experiments with solvent, 
BDE-99 (approx. IC50 concentrations) and 3 nM T3 or T4 are presented as mean + SEM (n = 3 (human), 
n = 4 (mouse)) after 5 days of differentiation. (C,F) Time-course results for solvent, BDE-99 (approx. IC50 
concentrations), 3 nM T3 and co-exposure are shown as mean ± SEM (n = 3 (human), n = 4 (mouse)). 
Significant differences (p < 0.05) from the solvent controls (of the respective day in C and F) are indicated as * 
and from BDE-99 treatment as #. The time-course curves of solvent controls (black curves in C,F) of human and 
mouse NPCs belonging to these experiments were previously published. This figure is not covered by the CC 
BY license. [Methods Pharmacol. Toxicol. Application of the Neurosphere Assay for DNT Hazard Assessment: 
Challenges and Limitations., 2016, 1–29, J. Baumann, K. Dach. M. Barenys, S. Giersiefer, J. Goniwiecha, P. J. 
Lein, E. Fritsche, Copyright holder: Springer Science+ Business Media New York]. All rights reserved, used with 
permission of Springer.
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(Fig. 3B), showing that the BDE-99-dependent reduction in hMBP expression was solely due to the lower number 
of O4+ cells, and thus TH-independent, while the TR antagonist NH-3 reduced QM without affecting cell viability 
(Supplementary Fig. S4) supporting a role for TR in T3-induced hMBP expression. In contrast, 10 μ M BDE-99 
(approx. IC50 inhibition of murine O4+ cell formation; 14 μ M BDE-99 are not medium-soluble with a DMSO 
concentration of 0.1%, Fig. 1) given alone or in combination with T3 reduced murine QM to 30% of the respective 
solvent control value (Fig. 3E) suggesting a TH-independent effect at this concentration. BDE-99 concentrations, 
however, that alone did not affect oligodendrocyte maturation (1–100 nM), significantly lowered T3-induced 
murine QM. The underlying molecular mechanism needs further elucidation (Fig. 3F).
TR involvement in TH and BDE-99 effects on mNPCs’ differentiation to O4+ cells and mMog 
gene expression. The involvement of TRs in T3 and BDE-99 effects on mNPCs’ differentiation to O4+ cells 
and mMog gene expression was studied using neurosphere cultures prepared from PND1 TRα and β knockout 
mouse brains. Number of O4+ cells/nuclei as well as mMog gene expression/% O4+ cells (QM) were normal-
ized to the respective genotype control because raw values did not differ significantly between genotype controls 
(Supplementary Fig. S5). T3 significantly induced number of O4+ cells/nuclei (Fig. 4A) and their maturation 
(Fig. 4B) in wildtype and TRβ , but not in TRα knockout neurospheres, confirming the specific involvement of 
TRα in T3-induced O4+ cell formation and maturation. On the contrary, BDE-99 effects on mouse O4+ cell for-
mation and oligodendrocyte maturation were not mediated by TRs, because 10 μ M BDE-99 reduced the number 
of differentiated O4+ cells as well as Mog expression/% O4+ cells in TR knockout neurospheres comparable with 
wildtype neurospheres (Fig. 4A,B).
To confirm that 10 μ M BDE-99 indeed does not interfere with TR-mediated TH signaling, expression of TRs, 
deiodinase 3 and hairless, the latter TR-dependent gene products, was evaluated. BDE-99 did not influence TR 
expression (Supplementary Fig. S2A–D) or TRα -mediated transcription of hairless alone or in combination with 
T3 (Supplementary Fig. S2E,F). Furthermore, BDE-99 did not alter basal or T3-induced deiodinase 3 expression 
(Supplementary Fig. S2G,H).
Reactive Oxygen Species (ROS) do not seem to be involved in BDE-99-dependent reduction of 
O4+ cells. Since our studies revealed that TH disruption was not the mechanism by which BDE-99 compro-
mised formation of human O4+ cells (Fig. 2B,C), we considered an alternative BDE-99 MoA, i.e. ROS formation. 
We hypothesized that the production of ROS might be involved in BDE-99-induced toxicity on O4+ cell forma-
tion. One indicator of ROS production is an adaptive induction of antioxidative defense gene expression like heme 
Figure 3. TH effects on basal and BDE-99-reduced mouse and human oligodendrocyte maturation. 
Human (A–C) and mouse (C–F) NPCs were differentiated with solvents, BDE-99 (approx. IC50 concentrations 
for formation of O4+ cells) and/or T3 for 1, 3 or 5 days (A,D) or 5 days (B,C,E,F). MBP (hNPCs) or Mog 
(mNPCs) expression was determined by real-time RT-PCR. Copy numbers of the genes were normalized 
to the expression of β-actin. (A,D) hMBP or mMog expression after 1, 3 and 5 days of NPC differentiation 
(mean + SEM, n = 3). * Indicates significant differences (p < 0.05) from the respective solvent control and # 
from the same treatment at day 1. (B,E,F) hMBP or mMog expression on day 5 was divided by the percentage 
of differentiated O4+ cells in the neurosphere mixed-cell migration area and then normalized to the mMog 
expression/% O4+ cells of the solvent control. As positive control data of 5 days differentiated hNPCs treated 
with solvents, TR antagonist NH-3 and/or T3 treatment is included (B). Data are shown as mean + SEM (n = 3). 
* Indicates significant differences (p < 0.05) from the control or # from the T3 treatment. (C) Representative 
fluorescence microscope pictures of 5 days differentiated human and mouse O4+ cells stained with antibody 
against O4 in presence of solvent or 3 nM T3 (scale bar: 50 μ m).
www.nature.com/scientificreports/
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oxygenase 1, catalase, superoxide dismutase and glutathione peroxidase. 2 μ M BDE-99 did not alter the expression 
of any of these genes after 24 hours of BDE-99 exposure suggesting that BDE-99 is not producing an excess of 
ROS in hNPCs (Fig. 5A). However, application of ascorbic acid (50 and 100 μ M, not inducing O4+ cell forma-
tion per se) antagonized the BDE-99-dependent reduction of human O4+ cell formation (Fig. 5B). As Trolox, a 
water-soluble derivative of vitamin E and effective ROS-scavenger, did not exert comparable antagonizing effects 
in presence of BDE-99 (Fig. 5C), it is likely that ascorbic acid rescues BDE-99-reduced O4+ cell formation by a 
mechanism other than ROS scavenging. In contrast to human O4+ cell formation, mouse O4+ cell formation 
was not rescued by ascorbic acid against BDE-99 (Fig. 5E). Also Trolox did not rescue murine O4+ cells against 
BDE-99-induced toxicity (Fig. 5F). It is to note, that for scavenging BDE-99 effects in mNPCs, lower Trolox con-
centrations (10 and 20 μ M) were used than for hNPCs since in mNPCs, 50 and 100 μ M Trolox reduced the culture 
viability and O4+ cell formation (data not shown).
Discussion
PBDEs were recently classified as human DNT compounds10. The molecular mechanisms of PBDE-induced DNT, 
however, remain elusive. PBDEs alter TH homeostasis in rodents and interfere with TH signaling in vitro49. In 
addition, BDE-99 reduced oligodendrocyte differentiation of human NPCs32. Because TH is crucial for oligoden-
drogenesis and/or myelin production in vivo17–19,50–52, we investigated in this study if disruption of cellular TH 
signaling in hNPCs and mNPCs might be an underlying molecular mechanism for BDE-99-mediated reduction 
of O4+ cell formation and oligodendrocyte maturation.
BDE-99 reduced human and murine O4+ cell formation in a concentration-dependent manner (IC50 1.9 μ M 
and 13.6 μ M, respectively and IC20 0.9 μ M and 6.9 μ M, respectively) with human NPCs being 7-times more sen-
sitive towards BDE-99 exposure than their murine counterparts. These data are in accordance with two other 
publications dealing with PBDE effects on oligodendrogenesis: our previous study with an IC50 for inhibiting 
human O4+ cell formation around 1 μ M BDE-9932 and inhibition of murine NSC differentiation into O4+ cells 
with an IC25 for BDE-47 of 10 μ M53.
The IC20 value for inhibiting human O4+ cell formation identified in this study lies in the upper nanomolar 
range (900 nM; approximately 450 ng/ml). Breast milk fed children are assumed to reach a daily PBDE exposure 
up to 306 ng/kg/day54,55 and the serum concentration of the five most abundant PBDEs reached 480 ng/g lipid 
weight (lw; approx. 960 nM in serum lipids) for Californian toddlers7. In vivo, up to a 1.5-fold accumulation of 
PBDEs in brain lipids compared to the corresponding serum lipid samples in birds56 and a 5.5 fold accumulation 
of BDE-47 in the rat brain versus serum57 were observed indicating that PBDEs pass the blood-brain barrier and 
accumulate in the brain. Assuming similar accumulation in human brain lipids, our rough kinetic estimation 
suggests that toddler PBDE brain lipid concentrations could exceed 720 ng/g lw (approx. 1440 nM in brain lipids), 
which is higher than the observed IC20 (900 nM) for human NPC differentiation in this study.
To test the hypothesis if TH disruption might be the underlying molecular mechanism for BDE-99-dependent 
inhibition of O4+ cell differentiation, we first characterized TH effects on human and mouse oligodendrogen-
esis. TH alone accelerated, but did not induce O4+ cell formation from hNPCs, while it induced the number of 
O4+ cells differentiated from mNPCs. In addition, TH enhanced human and murine oligodendrocyte matu-
ration. Accelerated oligodendrocyte maturation due to TH treatment was also observed in mouse and human 
Figure 4. TR involvement in TH and BDE-99 effects on mNPCs’ differentiation into O4+ cells and 
mMog gene expression. Neurospheres prepared from wildtype, TRα − /− and TRβ − /− mouse brains were 
differentiated for 5 days in the presence of solvents, 10 μ M BDE-99 and/or T3. (A) Immunocytochemical 
stainings of O4+ cells were performed and nuclei were counterstained with Hoechst 33258. The percentages of 
O4+-cells/nuclei are shown normalized to the respective genotype solvent controls (absolute percentage of O4+ 
cells does not differ between solvent treated wildtype and TR knockout neurospheres; Supplementary Fig. S5) 
(mean + SEM, n = 4). (B) mMog copy numbers determined by real time RT-PCR were first normalized to 
the β-actin expression, then divided by the percentage of O4+ cells and finally normalized to the mMog 
expression/% O4+ cells of the respective solvent control (maturation in solvent treated samples of wildtype and 
knockout mice did not differ). Data are shown as mean + SEM, n = 3 (wildtype), n = 4 (knockout). p < 0.05 
was considered as significantly different from the respective solvent control (*), BDE-99 treatment (#) or the 
respective wildtype treatment (′).
www.nature.com/scientificreports/
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oligodendrocyte precursor cells (OPCs)58 and in embryonic hNPCs differentiating into O4+ cells in vitro59 sup-
porting our findings. Moreover, similar to the rodent in vitro findings in this study, TH determines timing and 
amount of oligodendrocyte formation in rodents52,60–62 in a TRα -dependent manner63,64, and hypothyroid mice 
express lower levels of Mbp than euthyroid mice, which might be due to less oligodendrocyte formation, their 
reduced maturation or a combination of both52. Neurospheres prepared from TRα and TRβ knockout mice indi-
cated that TH-dependent induction of murine O4+ cell formation and oligodendrocyte maturation from mNPCs 
in vitro was also TRα -, not TRβ -dependent. Human patients with hypothyroidism during brain development also 
show delayed myelination15,16,65 due to less oligodendrocyte formation or maturation or a combination of both66. 
Our species-comparative in vitro study suggests that in contrast to mNPCs, TH mainly guides hNPC-derived 
oligodendrocyte maturation as supported by others58,59. Concerning the speed of O4+ cell formation and oligo-
dendrocyte maturation we found that these processes happen much faster in mouse than in human NPC cultures. 
Also in vivo oligodendrocytes form and mature much faster in rodents than in humans67. Thus, the closeness of 
the in vitro systems mirroring species-specific maturation speed strengthens the physiological relevance of our 
cell systems.
BDE-99 reduced NPC differentiation into O4+ cells in both species independent of TH as (i) human O4+ cell 
formation is not affected by TH and the TR antagonist NH-3 does not affect human NPC differentiation into O4+ 
cells (Supplementary Fig. S4) and (ii) BDE-99 reduces number of mouse O4+ cells in TH-induced neurospheres 
with the same magnitude than in untreated cells. Experiments with TRα and TRβ knockout mouse neurospheres 
support this data and add the information that TRs are not involved in BDE-99 action on O4+ cell formation. In 
accordance, BDE-99 did not inhibit T3-induced expression of hairless, a gene that is regulated by TRα in mice44 
and did not alter TR or T3-induced deiodinase 3 mRNA expression in either species.
As another possible MoA we postulated that the formation of ROS might be involved in BDE-99 toxicity on 
oligodendrogenesis. ROS formation by PBDEs is discussed controversially in the literature depending on the 
congener, cell type and method used49. BDE-99 did not up-regulate ROS-related genes in hNPCs and mNPCs 
and sub-cytotoxic concentrations of the antioxidant Trolox did not antagonize the BDE-99 effect on O4+ cell 
formation. Interestingly, ascorbic acid (50–100 μ M) rescued BDE-99-reduced O4+ cell formation in human, but 
not in mouse NPCs at concentrations not inducing oligodendrocytes in the cultures per se. A high ascorbic acid 
concentration (500 μ M) strongly induced formation of human, but not mouse O4+ cells (Supplementary Fig. S6). 
Ascorbic acid enables hydroxylation of proline to hydroxyproline68, a major component of the extracellular 
matrix protein collagen promoting rodent myelination of dorsal root ganglion neurons by Schwann cells in the 
peripheral nervous system69–71. The effects of ascorbic acid on central nervous system oligodendrogenesis are not 
known. However, the mechanism by which ascorbic acid antagonizes BDE-99-dependent reduction in human 
O4+ cell formation might involve collagen production. Interference of BDE-99 with mouse O4+ cell formation 
is clearly mediated by a different, yet unknown, MoA, as neither ascorbic acid nor Trolox antagonize this adverse 
effect.
Figure 5. Reactive Oxygen Species (ROS) do not seem to be involved in BDE-99-dependent reduction of 
O4+ cells. Human (A–C) and mouse (D–F) NPCs were differentiated for 24 h (A,D) or 5 days (B,C,E,F) in 
presence of solvent, BDE-99 and/or antioxidant (ascorbic acid or Trolox). Immunocytochemical O4 stainings 
(B,C,E,F) or gene expression studies by real-time RT-PCR (A,D) were performed. (A,D) Expression of the ROS-
related genes heme oxygenase-1 (HMOX-1/Hmox-1), catalase (CAT/Cat), superoxide dismutase (SOD/Sod) and 
glutathione peroxidase (GPX/Gpx) was evaluated with the Δ Δ CT method (housekeeping gene: β-actin; gene 
expression normalized to the expression in solvent sample). Results are shown as 2−ΔΔCT (mean + SEM, n = 3). 
(B,C,E,F) Percentage of O4+ cells/nuclei normalized to the solvent control (mean + SEM, n = 3–4). p < 0.05 was 
considered significantly different from solvent control (*) or from BDE-99 treatment (#).
www.nature.com/scientificreports/
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The maturation quotient QM demonstrated that BDE-99 at the IC50 concentration for O4+ cell formation did 
not affect human, but inhibited mouse gene expression related to oligodendrocyte maturation. These BDE-99 
effects on mMog expression were also independent of TH signaling as TH did not antagonize the effect and TR 
knockout neurospheres were not protected against BDE-99-dependent loss of O4+ cells. Moreover, ascorbic acid 
did not antagonize reduction of BDE-99-dependent mMog expression (Supplementary Fig. S7) pointing to a 
mechanism distinct from the MoA in hNPCs. BDE-99 concentrations, which did not interfere with basal O4+ cell 
differentiation or mMog expression, however, prohibited T3 induction of mMog by a yet unknown mechanism.
Another possibility that was not addressed within this paper but is worth exploring in the future is that 
BDE-99 does not directly act on oligodendrocytes, but exerts its actions indirectly e.g. via astrocyte signaling. 
Astrocytes play a major role in growth factor release like PDGF, FGF2, LIF, CNTF, IGF-1, NT-3, extracellular 
matrix-related molecules or BMPs, which obtain known functions in oligodendrogenesis19,72–74. These soluble 
factors have the ability to influence oligodendrocyte differentiation e.g. by epigenetic mechanisms and thus might 
provide a speculative rationale for BDE-99-dependent effects on oligodendrocyte differentiation via suppressed 
gene expression in cells of the oligodendrocyte lineage72. Unique features of the ‘Neurosphere Assay’ allowing 
investigations of such paracrine aspects in the future are its multicellularity, and the possibility to study multiple 
species in equivalent cell systems. However, in case of e.g. RT-PCR evaluation of cell type-specific markers the 
desired cell population might only be a fraction of the total cell number like in this study, where we find 6–8% 
oligodendrocytes after 5 days of differentiation34. With regards to the species comparison, the timing aspect has 
to be carefully considered as speed of developmental processes observed in neurospheres seem to reflect at least to 
some extent the pace of the species of cell origin, which is very different between humans and rodents33.
Conclusions
We developed a human and mouse NPC-based test system to identify compounds with adverse effects on oligo-
dendrogenesis including TH signaling disruptors. With this test we identified BDE-99 as an inhibitor of O4+ cell 
differentiation in both species and a blocker of oligodendrocyte maturation-related gene expression (mMog) only 
in mouse cultures. BDE-99 effects follow unknown MoAs in both species, but ascorbic acid rescued inhibited O4+ 
cell differentiation only in human cultures, while it exerted no effect on any of the endpoints studied in mouse 
neurospheres. This study indicates the need to consider species differences in susceptibility and MoA analyses of 
chemicals for their DNT potential and thus suggests the necessity of using human cells for human hazard charac-
terization of compounds that might be toxic for the developing brain.
Methods
Chemicals. Brominated diphenyl ether (BDE)-99 was kindly provided by U. Strähle from the Karlsruhe 
Institute of Technology, thyroid hormones (THs) L-3,3′ ,5- triiodothyronine (T3) and L-3,3′ ,5,5′ - tetraiodothy-
ronine (T4), L-ascorbic acid and Trolox (vitamin E analog) were purchased from Sigma Aldrich. Chemicals 
were dissolved as follows: 1, 2, 6.66, 10 mM stocks of BDE-99 in dimethyl sulfoxide (DMSO; Carl Roth GmbH), 
300 μ M T3 or T4 in a 1:1 dilution of 96% ethanol and 1 M HCl (both Carl Roth GmbH) (‘EtOH/HCl’), 100 mM 
ascorbic acid in H2O, 200 mM Trolox in DMSO. TR antagonist NH-375 was diluted in DMSO and a 1 mM stock 
was prepared. Solvent concentrations used in the experiments were 0.1% (co-treatment experiments) or 0.3% 
(dose-response experiments) DMSO for BDE-99, 0.1% DMSO for NH-3, 0.01% EtOH/HCl (T3, T4), 0.05% 
DMSO (Trolox), 0.1% or 0.5% H2O (L-ascorbic acid) or the respective combination in the co-treatments. For 
antagonization experiments, IC50 concentrations for BDE-99 (2 μ M and 10 μ M (approx.) for hNPCs and mNPCs, 
respectively − 14 μ M BDE-99 are not medium-soluble with a DMSO concentration of 0.1%) were chosen.
Neurosphere Culture. Human neural progenitor cells (gestational week (GW) 16–20) were purchased 
from Lonza Verviers SPRL (Belgium). Developmental time-matched76 mouse NPCs from postnatal day (PND) 
1 were prepared as described previously for rat NPCs77 with the modification that only the mouse forebrain 
was used and digested with papain for 7 min. Experiments with human NPCs purchased from Lonza Verviers 
SPRL (Belgium) are ethical approved by the ethics committee of the Heinrich-Heine-University, Düsseldorf. 
Preparation of NPCs from mouse brain tissue and experiments with mouse NPCs are in accordance with 
German regulations and the experimental guidelines of the State Agency for Nature, Environment and Consumer 
Protection in North Rhine-Westphalia in Germany (LANUV) and are approved by the LANUV (license number: 
84–02.05.40.14.140). To study the involvement of TH receptors (TRs) in oligodendrogenesis, NPCs from TRα 
and TRβ knockout mice were prepared. Human and mouse NPCs were cultured as neurospheres in proliferation 
medium consisting of DMEM (Life Technologies) and Hams F12 (Life Technologies) (3:1) supplemented with 
2% B27 (Life Technologies), 20 ng/ml epidermal growth factor (EGF, Life Technologies), 20 ng/mL (hNPCs) or 
10 ng/ml (mNPCs) recombinant human fibroblast growth factor (FGF, R&D Systems), and 1% penicillin and 
streptomycin (Pan-Biotech). Neurospheres were maintained at 37 °C with 5% CO2 and passaged mechanically 
with a tissue chopper to 0.2 mm once a week. Half of the medium was replaced thrice a week.
Differentiation of NPCs. NPCs were chopped to 0.2 mm 1–3 days (hNPCs) or 3–5 days (mNPCs) before 
plating. The longer time between chopping and plating is due to the fact that mouse neurospheres need longer 
to regenerate and form even, round spheres again. Human or mouse NPCs were differentiated in differentia-
tion medium [DMEM (Life Technologies), Hams F12 (Life Technologies) 3:1 supplemented with 1% of N2 (Life 
Technologies) and 1% penicillin and streptomycin (Pan-Biotech) and only for the mouse 1% hormone-free fetal 
calf serum (FCS; Biochrom) to prevent apoptosis was added] containing the respective exposure(s) or solvent(s). 
Half of the exposure/solvent medium was refreshed at day 2 of differentiation. Under differentiating conditions 
NPCs radially migrate out of the neurosphere core (migration area) and differentiate into the three major cell 
types of the brain: neurons, oligodendrocytes and astrocytes78,79.
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Differentiation of NPCs for viability measurement and staining of O4+ cells. Neurospheres of 0.3 mm diameter 
were washed in differentiation medium and plated into poly-D-lysine (PDL)/laminin (Sigma Aldrich) coated 
8-chamber glass cover slides (LMS Consult). In each chamber, five neurospheres were plated in 500 μ l differen-
tiation medium containing the respective exposure(s) or solvent(s). Neurospheres were differentiated for 5 days 
or in the time course experiment for 1, 2, 3, 4 and 5 days, where 5 slides were plated on the same day and one was 
fixed each day. Each experiment was repeated at least 3 times. Mean and SEM were calculated from those repeated 
experiments.
Differentiation of NPCs for RT-PCR. Neurospheres were differentiated in PDL/laminin coated wells of 24 well 
plates (Sarstedt) in 1 ml differentiation medium containing the respective exposure(s)/solvent(s). Three wells with 
ten 0.3 mm neurospheres each were used per exposure condition. Neurospheres were differentiated for 5 days or 
in time course experiments for 1, 3 and 5 days, where 3 plates were plated at the same day and cells in one plate 
were lysed on each day 1, 3 or 5 of differentiation. Each experiment was repeated at least 3 times. Mean and SEM 
were calculated from those repeated experiments.
Viability assay. Cell viability was assessed using Alamar Blue reagent (CellTiter-Blue assay, Promega) by meas-
uring mitochondrial reductase activity after 5 days of differentiation in the same slides which cells were later fixed 
and immunocytochemically stained for O4+ cells. The reagent was pre-diluted 1:3 in differentiation medium and 
added to the chambers (1:4) two hours prior to fixation. The neurospheres were incubated for 2 h at 37 °C and 5% 
CO2. The incubated reagent was pipetted into a 96-well plate in technical duplicates of 100 μ l to determine fluores-
cence with the Tecan infinite M200 Pro reader (ex: 540 nm; em: 590 nm). Background of only medium without cells 
was subtracted from the sample RFU values. Duplicate RFU values from each chamber were pooled. Each viability 
experiment was repeated at least three times independently. Mean and SEM were calculated from those repeated 
experiments. Viability data which are not included in the main manuscript are shown in the Supplementary Fig. S3.
Immunocytochemistry. After the respective differentiation times (and viability measurement) neuros-
pheres were fixed with 4% paraformaldehyde (PFA, Merck) at 37 °C for 30 min and stored in phosphate buffered 
saline (PBS; Biochrom) at 4 °C until the immunocytochemical staining for O4 was performed. Cells were stained 
overnight with 30 μ l first antibody solution (1:200 mouse IgM anti-O4 antibody (R&D Systems), 10% goat serum 
(Sigma Aldrich) in PBS) per chamber. After three 5 min washing steps in PBS 30 μ l secondary antibody solution 
(1:250 Alexa Fluor 488 anti-mouse IgM (Life Technologies), 2% Hoechst 33258, 1% goat serum in PBS) were 
added per chamber and cells were stained for 30 min at 37 °C. After three additional 5 min washing steps in 
PBS, cells were washed once in distilled water and then the slide was mounted with a glass cover slip by using 
AquaPolyMount (Polysciences).
Fluorescence microscopy and quantification of O4+ cells. In each experiment five neurospheres/treat-
ment and two fluorescence images/neurosphere, taken at defined, opposite sides of the neurosphere core (in the 
same distance to the neurosphere core for each differentiation day), were evaluated resulting in 10 image evaluations/
treatment/experiment. Images were taken using two channels of a fluorescent microscope (Zeiss, Axio Observer 
D1): ex: 359 nm; em: 461 nm for visualizing Hoechst staining and ex: 495 nm; em: 519 nm for O4 evaluation. Images 
were converted to 8-bit, binarized and watershed transformed for quantification of the number of nuclei by using an 
ImageJ macro. Only segments satisfying suitable size constraints (x-y) were considered as valid nuclei. O4+ cells were 
counted manually. Then the percentage of O4+ cells/nuclei was calculated for each picture and the percentages were 
pooled between the two pictures of the same neurosphere. Afterwards the mean and standard deviation between the 
five neurospheres was calculated for each treatment. The solvent control was set to 100% (except for the time-course 
experiment showing formation of O4+ cells over time). Each figure contains data from at least three independent 
experiments and for each condition mean and SEM were calculated from those independent experiments.
On average for all O4+ cell formation experiments included in the manuscript, solvent controls of hNPCs con-
tained 620 nuclei and 38 O4+ cells per image (6% O4+ cells) and of mNPCs with a less dense migration area 310 
nuclei and 18 O4+ cells (6% O4+ cells) per image. For ten microscope pictures per solvent control this ends up in 
approximately 380 O4+ cells/6200 nuclei for hNPCs and 180 O4+ cells/3100 nuclei for mNPCs per n. Substance 
treatment does not change the amount of nuclei per picture, but only the amount of O4+ cells.
Quantitative RT-PCR (qRT-PCR). RNA of untreated proliferating (triplicated samples of 50 neurospheres 
with a 0.3 mm diameter were collected 2 (hNPCs) or 3 (mNPCs) days after chopping) or 1,3 or 5 days under 
exposures/solvents differentiated NPCs (as described above) was isolated (RNeasy Mini Kit, Qiagen, Hilden, 
Germany) and cDNA was transcribed (Quantitect Reverse Transcription Kit, Qiagen) according to the manu-
facturer instructions. qRT-PCR was performed using QuantiFast SYBR Green PCR Kit (Qiagen) in the Rotor 
Gene Q cycler (Qiagen). Copy numbers of the gene of interest were normalized to β-actin expression by using 
standards or expression was evaluated by the ddCT method normalizing to β-actin expression in the solvent 
control samples. Each PCR experiment was performed at least three times independently. Means and SEMs were 
calculated from those independent experiments. The detailed PCR protocol and details for evaluation as well as 
the used primer sequences are given in the Supplementary Material.
Statistics. For dose-response curves a sigmoidal curve fit (variable slope) was applied using Graphpad Prism 
6.0. Data was analyzed with the same software using OneWay ANOVA for dose-response experiments, TwoWay 
ANOVA for co-exposure and time-course experiments (non-repeated measures) or a student’s t-test for compari-
son of wildtype and knockout mice within the same treatment. As post-hoc tests Bonferroni’s (OneWay ANOVA) 
or Tukey’s (TwoWay ANOVA) multiple comparison test were used. T-tests were performed with Welsh’s correc-
tion assuming different standard deviations for the treatments. Significance threshold was established at p < 0.05.
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